Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Valneva SE, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Valneva SE, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Valneva SE, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Valneva SE, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Valneva SE, Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Valneva SE, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Valneva SE, Pharmaceuticals &Healthcare, Deal Details | 12 | 23 |
| Venture Financing | 12 | 1 |
| Valneva to Secure USD18 Million from Funds Managed by Athyrium | 12 | 1 |
| BliNK Biomedical Raises Funds through Series A Venture Financing | 13 | 2 |
| Valneva Austria Raises US$30 Million In Venture Financing | 15 | 1 |
| Partnerships | 16 | 1 |
| Seqirus Enters into Distribution Agreement with Valneva | 16 | 1 |
| Valneva Enters into R&D Agreement with GlaxoSmithKline | 17 | 1 |
| Valneva Enters into Distribution Agreement with PaxVax | 18 | 1 |
| PaxVax Enters into Distribution Agreement with Valneva | 19 | 1 |
| Valneva Forms Joint Venture with BliNK Therapeutics | 20 | 1 |
| Licensing Agreements | 21 | 1 |
| Valneva Enters into Licensing Agreement with Jianshun Biosciences | 21 | 1 |
| Valneva Enters into Licensing Agreement with Immune Targeting Systems for IC31 Adjuvant | 22 | 1 |
| Valneva to Enter into Licensing Agreement with Pharma Company | 23 | 1 |
| Valneva to Enter into Licensing Agreement with Japan-Based Animal Vaccine Manufacturer | 24 | 1 |
| GeoVax Labs Enters into Licensing Agreement with Valneva | 25 | 1 |
| Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine | 26 | 1 |
| Valneva Enters into Research Licensing Agreement with Emergent BioSolutions for EB66 Cell Line | 27 | 1 |
| Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine | 28 | 1 |
| Equity Offering | 29 | 1 |
| Valneva Raises USD54 Million in Rights Offering | 29 | 2 |
| Valneva Completes Rights Offering Of Shares For US$53.5 Million | 31 | 2 |
| Asset Transactions | 33 | 1 |
| Valneva To Sell Clinical Manufacturing Operations Facility To Biological E | 33 | 1 |
| Acquisition | 34 | 1 |
| Valneva Acquires Crucell Sweden for USD54 Million | 34 | 1 |
| Valneva SE - Key Competitors | 35 | 1 |
| Key Employees | 36 | 1 |
| Locations And Subsidiaries | 37 | 2 |
| Head Office | 37 | 1 |
| Other Locations &Subsidiaries | 37 | 2 |
| Appendix | 39 | 1 |
| Methodology | 39 | 1 |
| About GlobalData | 39 | 1 |
| Contact Us | 39 | 1 |
| Disclaimer | 39 | 1 |